AC Immune SA Statistics
NASDAQ: ACIUHealth CareBiotechnology: Pharmaceutical PreparationsUSD
1.95-0.18 (-8.45%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
AC Immune SA by the numbers
AC Immune SA has a market capitalization of $193.9 million based on 99.43M shares outstanding. With trailing EPS of $-0.44, AC Immune SA is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 19.6% below its 50-day average and 26.0% below its 200-day average.
Average daily trading volume is 198.81K shares, or about $387,680 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ACIU valuation vs. peer median
| Metric | ACIU | Peer median | Difference |
|---|---|---|---|
| Market cap | $193.88M | $197.61M | -2% |
| Avg. volume | 198.81K | 367.01K | -46% |
Peer median across 8 companies: ANTX, YARW, BIOA, NGEN, RNAC, DRUG, BCYC, FTH.
Valuation
- Market cap
- $193.88M
- Forward P/E
- 2.84
- EPS (TTM)
- $-0.44
- Shares outstanding
- 99.43M
Price and trading
- Previous close
- 2.13
- Open
- 2.13
- Day range
- 1.93 – 2.15
- 52-week range
- 1.93 – 3.90
- 52-week change
- -35.00%
- Beta
- —
- Volume
- 297.66K
- Average volume
- 198.81K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 4, 2026
Additional statistics
- Market Cap
- 193.88M
- Forward Pe
- 2.84
- Eps
- -0.44
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 3.90
- Week52 Low
- 1.93
- Avg Volume
- 198.81K
- Shares Outstanding
- 99.43M
- Ma50
- 2.43
- Ma200
- 2.63
- Earnings Date
- Nov 4, 2026
- Pct From52w High
- -50.00%
- Pct From52w Low
- 1.04%